secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001459839-24-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE reports record Q4 revenue $38.9M (+22% YoY); FY23 revenue $138.9M (+31%); issues FY24 guidance $162-165M
--------------------------------------------------------------------------------

- Q4 worldwide revenue $38.9M (+22% YoY); US revenue $36.7M (+22%); gross margin 74% (down from 84%) due to $1.7M excess inventory reserve.
- FY23 worldwide revenue $138.9M (+31% YoY); US revenue $130.6M (+32%); net loss improved 29% to $43.3M; adjusted EBITDA loss improved 48% to $17.3M.
- Over 1,600 US physicians performed >15,000 procedures in 2023; active physicians grew 22% to >1,130 in Q4.
- FY24 guidance: revenue $162-165M (17-19% growth); gross margin ~78%; OpEx growth ~9%; expects significant adjusted EBITDA improvement.
- Cash and equivalents ~$166M; net cash usage ~$0.8M in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000010/0001459839-24-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000010/sibn-20240226.htm
  HTML page:      https://secwatch.observer/filing/0001459839-24-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer